MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why BTMD Stock advanced +1.74% Today — RQD Quant Desk Flash
$1.17 +1.74% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.17
Biote Corp. (Class A) (BTMD) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C • HOLD / WATCH
Cap $42.0M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.17 (+0.12%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 15.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 62/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.7% avg 90D alpha vs SPY • 54.3% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw C · Rk C
Each axis scored 0–20
12M PRICE TARGET CONE+1.7% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BTMD)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (62/100 Composite)
🔍 WHY BTMD SCORES 62/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+14/20 pts (23% of score)
SEC XBRL FY 2025 (10-K): 15.7% FCF Margin ($30.2M FCF) & 52% Gross Margin
▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (21% of score)
FRED Regime × Technicals: 9% of 52W Range • RSI-14 at 43.5 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$1.15-5.2% Next Q
54
Q2 (-2Q)Grade C$1.09-1.8% Next Q
57
Q3 (-1Q)Grade C$1.07+9.3% Next Q
59
CurrentGrade C$1.17+0.7% Hist 90D α
62
Trajectory: C- (54) → C (62)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the BTMD Bull Thesis Could Fail
Even with a 62/100 (C) score, BTMD faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($1.29) or 200D SMA ($1.83) invalidates the momentum regime and cuts Target Base ($1.19) toward Bear Floor ($0.93).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $BTMD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BTMD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why BTMD Stock advanced +1.74% Today — RQD Quant Desk Flash
Biote Corp. (Class A) (BTMD) advanced +1.74% to $1.17, trading at 9% of its 52-week range ($1 – $2.98). Solid steady margins (85% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 9% of its 52-week range ($1 – $2.98) with RSI-14 at 43.5 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.17 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 52% gross margin and $30.2M annual free cash flow.
Live BTMD Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (BTMD Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BTMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -47.30%⚡ TESTING RESISTANCE
2026-10-30O $1.17H $1.20L $1.11C $1.17VOL 65.6K
RES: $1.22SUP: $0.90SMA50: $1.29SMA200: $1.83
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
BTMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
-15.0%/yr Implied 5Y Growth
vs. -2.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on BTMD today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for BTMD. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BTMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BTMD)
Health Care Rank #176 of 1016
⚔️ FTLF vs BTMD Full Matrix →
1. Head-to-Head Health Care Peer Comparison (BTMD vs. FTLF, ISPR, MTEX, MDWD)
Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Biote Corp. (Class A) (BTMD) ranks #176 by composite RQD confidence (62/100, grade C) and #768 by equity capitalization ($42.0M). Within this direct 5-issuer industry benchmark cohort, FTLF leads on earnings valuation at 11.7x trailing P/E, while BTMD leads on capital efficiency and profitability with 85.0% ROIC and — gross margin. BTMD currently leads its immediate peer cohort in composite quantitative strength at 62/100 (C).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BTMD
ACTIVE
Biote Corp. (Class A) | C | 62/100 | — | — | 85.0% | +1.74% | $42.0M | Benchmark Subject |
| FTLF FitLife Brands Inc. | D | 48/100 | 11.7x | 43.1% | 5.4% | -4.70% | $74.3M | /ftlf-vs-btmd → |
| ISPR Ispire Technology Inc. | E | 27/100 | — | 17.8% | -35.0% | -1.44% | $79.1M | /ispr-vs-btmd → |
| MTEX Mannatech Incorporated | E | 33/100 | — | 74.9% | -35.0% | -2.23% | $16.1M | /mtex-vs-btmd → |
| MDWD MediWound Ltd. | C- | 60/100 | — | — | — | +2.21% | $178.9M | /mdwd-vs-btmd → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001819253In its most recent audited fiscal period (FY2025, filed 2025-12-31), Biote Corp. (Class A) (BTMD) reported GAAP revenue of $192.2M (-2.5% vs. FY2024 revenue of $197.2M , and +3.7% cumulative change since FY2023) , GAAP net income of $27.0M, operating cash flow of $35.2M, and free cash flow of $30.2M (-22.2% YoY). On the balance sheet, BTMD closed FY2025 with $107.6M in total assets against $95.8M in total debt (Altman Z-Score: 2.50, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $192.2M | $27.0M | $35.2M | $30.2M | $107.6M | $95.8M |
| FY2024 (FY) | 2024-12-31 | $197.2M | $3.2M | $45.2M | $38.8M | $122.4M | $101.2M |
| FY2023 (FY) | 2023-12-31 | $185.4M | $3.3M | $26.9M | $26.9M | — | — |
3. BTMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BTMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Biote Corp. (Class A) (NASDAQ: BTMD) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $1.17 (+1.74% 1D, market cap $42.0M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, BTMD ranks #176 in composite RQD confidence.
How does BTMD compare to FTLF and ISPR in the Health Care sector?
Within the Health Care sector (Medicinal Chemicals and Botanical Products), BTMD carries a Roarable C (62/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 85.0%. By comparison, FTLF (FitLife Brands Inc.) holds a D grade (48/100 RQD, P/E 11.7x, ROIC 5.4%, cap $74.3M) and ISPR (Ispire Technology Inc.) posts a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $79.1M). Among the 5-stock peer group, FTLF leads on earnings multiple (11.7x) while BTMD leads on capital efficiency (85.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BTMD?
Per BTMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001819253), Biote Corp. (Class A) generated $192.2M in revenue (-2.5% YoY), $27.0M in net income, and $30.2M in free cash flow against $107.6M in total assets and $95.8M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BTMD trading relative to its 50-day, 200-day, and 52-week technical levels?
BTMD last traded at $1.17 (+1.74% on volume of 127,002 shares), positioning the stock -9.30% below its 50-day simple moving average ($1.29) and -36.07% below its 200-day simple moving average ($1.83). Across its 52-week range of $1.00 to $2.98, BTMD sits at the 8.6% percentile with a 14-day RSI of 43.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.02 to $1.32).
BTMD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BTMD stock moving today?
Why BTMD Stock advanced +1.74% Today — RQD Quant Desk Flash. Solid steady margins (85% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.